#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukocyte adhesion deficiency type I Follicle centre lymphoma follicular grade I II – III refractory Penile cancer Pseudomyxoma peritonei Microscopic polyangiitis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Neurodermatitis Thalassaemia Autoinflammation with infantile enterocolitis Thrombotic microangiopathy Retinopathy of prematurity Renal disorder Paroxysmal nocturnal haemoglobinuria Diffuse large B-cell lymphoma Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic Leiomyosarcoma recurrent – Life with Disease Myelodysplastic syndrome with excess blasts Ocular melanoma – Basic Information Biotinidase deficiency – Diagnostics Fragile X syndrome – Life with Disease Proteus syndrome – Treatment Tuberous sclerosis complex Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Rhabdoid tumour – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olaptesed Pegol 177LU-PSMA-I&T Glutenin Cipaglucosidase Alfa Idarubicin Cyclophosphamide Monohydrate Emrusolmin FLUORIDE Basiliximab Egl-001 Tramadol Tenofovir Disoproxil Ampreloxetine DICLOFENAC POTASSIUM Afamelanotide VOXVOGANAN Sodium Hydrogen Carbonate Levodopa Dupilumab Alendronic Acid More therapies…

    Learn about Your Condition

    Respiratory distress Hernia repair Diabetes insipidus Metastases to peritoneum Arginase deficiency Indolent systemic mastocytosis Angina pectoris Osteomyelitis Small cell lung cancer Osteonecrosis of jaw Rabies Adenomyosis Acute myeloid leukaemia Prodromal Alzheimer's disease Retinitis pigmentosa More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)

    Recruiting

    4 1 1
    Investigated Drugs:
    • Sibeprenlimab
    Belgium Croatia Czechia France Germany Greece +6

  • Study on Pain Relief Using Levobupivacaine Hydrochloride for Patients Undergoing Laparoscopic Colorectal Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levobupivacaine Hydrochloride
    Spain

  • Study on Edoxaban and Drug Combination for Patients with Atrial Fibrillation Needing Anticoagulation After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Phenprocoumon
    • Warfarin
    • Dabigatran
    Germany

  • Study on Phenoxymethylpenicillin for Patients with Severe Streptococcus Group A-Negative Acute Tonsillitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tonsillitis
    Investigated Drugs:
    • Benzathine Benzylpenicillin
    Sweden

  • Study of Mirikizumab for Children and Teens with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Germany Italy The Netherlands +4

  • Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytisine
    Poland
Previous Page
1 … 545 546 547 548 549 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!